These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [Better informed decisions in the management of osteoporosis]. Alonso-Coello P; Bonfill X Reumatol Clin; 2011; 7(1):1-2. PubMed ID: 21794771 [No Abstract] [Full Text] [Related]
63. Hip fractures after stroke and their prevention. Myint PK; Poole KE; Warburton EA QJM; 2007 Sep; 100(9):539-45. PubMed ID: 17693418 [TBL] [Abstract][Full Text] [Related]
64. [Treatment goals of osteoporosis]. Hosoi T Clin Calcium; 2014 Mar; 24(3):385-9. PubMed ID: 24576935 [TBL] [Abstract][Full Text] [Related]
67. Osteoporosis drugs. Current and future options. Mayo Clin Health Lett; 2012 Nov; 30(11):7. PubMed ID: 23795362 [No Abstract] [Full Text] [Related]
68. Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones? Vestergaard P Calcif Tissue Int; 2012 Jan; 90(1):22-9. PubMed ID: 22120197 [TBL] [Abstract][Full Text] [Related]
69. [Diagnosis and treatment of osteoporosis in men]. Hosoi T Nihon Rinsho; 2007 Nov; 65 Suppl 9():495-8. PubMed ID: 18161155 [No Abstract] [Full Text] [Related]
70. [The influence of bisphosphonates on fracture healing]. Seebach C; Kurth A; Marzi I Orthopade; 2007 Feb; 36(2):136-40. PubMed ID: 17242960 [TBL] [Abstract][Full Text] [Related]
71. [Perspective for development of parathyroid hormone and related compounds as therapeutic agents for osteoporosis]. Ikeda K; Fukagawa M Nihon Rinsho; 2005 Oct; 63 Suppl 10():367-71. PubMed ID: 16279664 [No Abstract] [Full Text] [Related]
73. [Osteoporosis]. Uebelhart B; Rizzoli R Rev Med Suisse; 2013 Jan; 9(369):125-31. PubMed ID: 23409650 [TBL] [Abstract][Full Text] [Related]
74. Prevention of hip fractures: drug therapy. Lips P Bone; 1996 Mar; 18(3 Suppl):159S-163S. PubMed ID: 8777082 [TBL] [Abstract][Full Text] [Related]
75. [New therapy using bisphosphonate for urolithiasis]. Yasui T; Niimi K; Hirose M Clin Calcium; 2011 Oct; 21(10):1511-5. PubMed ID: 21960237 [TBL] [Abstract][Full Text] [Related]
76. Secondary prevention of hip fractures among the hospitalized elderly: are we doing enough? Kamel HK J Clin Rheumatol; 2005 Apr; 11(2):68-71. PubMed ID: 16357705 [TBL] [Abstract][Full Text] [Related]
77. [Evaluation methods of therapeutic effects of drugs for osteoporosis]. Ishibashi H Clin Calcium; 2012 Jun; 22(6):890-5. PubMed ID: 22653030 [TBL] [Abstract][Full Text] [Related]
78. [Hip Fracture--Epidemiology, Management and Liaison Service. Medicines that prevent hip fracture]. Uchiyama S Clin Calcium; 2015 Apr; 25(4):505-9. PubMed ID: 25814011 [TBL] [Abstract][Full Text] [Related]
79. Bisphosphonates in the treatment of osteoporosis. Poole KE; Compston JE BMJ; 2012 May; 344():e3211. PubMed ID: 22619192 [No Abstract] [Full Text] [Related]
80. ENDOCRINOLOGY AND ADOLESCENCE: Osteoporosis in children: diagnosis and management. Saraff V; Högler W Eur J Endocrinol; 2015 Dec; 173(6):R185-97. PubMed ID: 26041077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]